Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in German...
Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Springer
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer
Subjects
More information
Scope and Contents
Contents
Background In 2009, the European Medicines Agency granted approval for two higher-valent pneumococcal conjugate vaccines. This study aims to evaluate the costeffectiveness of universal infant (<2 years old) vaccination with a 13-valent pneumococcal conjugate vaccine (PCV13) in comparison with a 10-valent pneumococcal conjugate vaccine (PCV10) for t...
Alternative Titles
Full title
Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1826666299
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1826666299
Other Identifiers
ISSN
1618-7598
E-ISSN
1618-7601
DOI
10.1007/s10198-016-0770-9
